Drug recall · April 21, 2021
Lidocaine Ointment USP recall
Why: Failed Stability Specifications: product did not meet viscosity results.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Lidocaine Ointment USP, 5%, NET WT 35.44 g (1 1/4 Oz) tube, Rx Only, Teligent Pharma Inc., Buena, New Jersey, 08310, NDC 52565-008-14.
- Lots / codes
Lot 13269, Exp March 2021
- Quantity
- 62,040 tubes
- Company
- Teligent Pharma, Inc., Buena, NJ
- Distribution
- Nationwide in the USA
- Initiated
- March 29, 2021 · Voluntary: Firm initiated
- Classified
- April 12, 2021
- Reported
- April 21, 2021
- Ended
- July 3, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lidocaine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.